VaramirStart free · no cardSign in
JANX as of Oct 31 · 00:14 ET
JANXNasdaqPharmaceutical Preparations

Janux Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±13.8%
avg realized
±2.7%
Nov 6 '24±17.2%▼−1.24%×0.07
Feb 27 '25±16.0%▲+2.75%×0.17
May 8 '25±10.4%▼−3.07%×0.30
Aug 7 '25±12.6%▲+1.11%×0.09
Q3 FY25±21.6%▼−7.61%×0.35
Q1 FY26±12.2%▼−1.38%×0.11
May 7 '26±9.4%▼−2.51%×0.27
Q2 FY26±10.7%▼−1.55%×0.14
quarterimplied−25%0+25%realized×
Q2 FY26±10.7%▼−1.55%×0.14
May '26±9.4%▼−2.51%×0.27
Q1 FY26±12.2%▼−1.38%×0.11
Q3 FY25±21.6%▼−7.61%×0.35
Aug '25±12.6%▲+1.11%×0.09
May '25±10.4%▼−3.07%×0.30
2 older reports
Feb '25±16.0%▲+2.75%×0.17
Nov '24±17.2%▼−1.24%×0.07
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

196managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+14.57%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

4tracked funds holding JANXN-PORT · Aug 31 '26
0.28%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

JANX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±16.9% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.